Business Context and Reporting Period
Company: Bioceres Crop Solutions Corp.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: September 15, 2026
Reporting Period: Fiscal fourth quarter and fiscal year ended June 30, 2026.
This filing primarily addresses a regulatory matter regarding the Company's listing status on The Nasdaq Stock Market and incorporates by reference the earnings release for the fiscal year ended June 30, 2026.
Key Financial Metrics
The filing text incorporates the earnings release for the fiscal fourth quarter and fiscal year ended June 30, 2026, as Exhibit 99.1. However, the specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not provided within the body of this Form 6-K text. Investors must refer to the attached press release (Exhibit 99.1) for detailed financial data.
Material Changes and Listing Status
- Nasdaq Transfer: The Company received approval to transfer its ordinary shares from The Nasdaq Global Market to The Nasdaq Capital Market, effective September 18, 2026.
- Minimum Bid Price Deficiency: The Company failed to maintain the required minimum closing bid price of $1.00 per share during the initial 180-day compliance period ending September 14, 2026.
- Extended Compliance Period: Nasdaq granted an additional 180-calendar-day compliance period, extending until March 15, 2027, to regain compliance with the Minimum Bid Price Requirement.
- Compliance Conditions: To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days during the new period. If a reverse stock split is utilized, it must be completed no later than 10 business days prior to March 15, 2027.
Outlook, Risks, and Contingencies
Management Commentary: The Company intends to monitor its closing bid price and evaluate all available options to regain compliance, including a potential reverse stock split. There is no assurance that compliance will be achieved or that the Company will remain in compliance with other listing requirements.
Key Risks and Uncertainties:
- Delisting Risk: Failure to demonstrate compliance by March 15, 2027, may result in written notification of delisting, subject to appeal.
- Operational and Legal Risks: Forward-looking statements are subject to risks including ongoing litigation, the ability to secure additional financing, and macroeconomic conditions in Argentina.
- Specific Contingency: The outcome of the Pro Farm foreclosure and transition process is cited as a material uncertainty.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, cash position) in the attached Exhibit 99.1 press release, as they are not detailed in this summary text.
- Monitor the daily closing bid price of BIOX shares to assess progress toward the $1.00 threshold required for Nasdaq compliance.
- Watch for announcements regarding a potential reverse stock split, which must be executed by early March 2027 if the price target is not met organically.
- Review updates on the Pro Farm foreclosure process and any new litigation developments that could impact liquidity or operations.